Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia

Natalie Rafaeli, David Marin, Celina Ledesma, Nitin Jain, Priti Tewari, Issa F. Khouri, Amanda L. Olson, Gheath Alatrash, Nicholas J. Short, Elias Jabbour, Katy Rezvani, Amin M. Alousi, Uday Popat, Richard E. Champlin, Elizabeth J. Shpall, Partow Kebriaei

Blood (2024) 144 (Supplement 1): 2810.

https://doi.org/10.1182/blood-2024-193954

Published: 2024

Journal Articles

First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Blood (2022) 140 (Supplement 1): 2120–2122.

https://doi.org/10.1182/blood-2022-159183

Published: 2022

Journal Articles

HLA B-Leader Mismatch Is Associated with Poor Outcomes in NIMA/NIPA Mismatched Haploidentical Sibling Donor HCT

Rohtesh S. Mehta, Rima M. Saliba, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R. Popat, Muzaffar H. Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A. Srour, Katy Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Kai Cao

Blood (2022) 140 (Supplement 1): 4880–4881.

https://doi.org/10.1182/blood-2022-158689

Published: 2022

Journal Articles

Mother Vs Father Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

Rohtesh S. Mehta, Rima M. Saliba, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R Popat, Muzaffar H Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A Srour, Katy Rezvani, Richard E Champlin, Elizabeth J Shpall, Kai Cao

Blood (2022) 140 (Supplement 1): 10530–10531.

https://doi.org/10.1182/blood-2022-166472

Published: 2022

Journal Articles

A Phase II Clinical Trial of "Off-the-Shelf" NK Cells with Allogeneic Stem Cell Transplantation to Decrease Disease Relapse in Patients with High-Risk Myeloid Malignancies

Jeremy L. Ramdial, Lorlyn Clemente-Sevilla, Doris Soebbing, Bouthaina S. Dabaja, Peter F Thall, Gheath Alatrash, Amin M Alousi, Rohtesh S. Mehta, Uday R Popat, Partow Kebriaei, Betul Oran, Katy Rezvani, Elizabeth J Shpall, Richard E Champlin

Blood (2022) 140 (Supplement 1): 7484–7485.

https://doi.org/10.1182/blood-2022-170663

Published: 2022

Journal Articles

Son Vs Daughter Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

Rohtesh S. Mehta, Rima M. Saliba, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R Popat, Muzaffar H Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A Srour, Katy Rezvani, Richard E Champlin, Elizabeth J Shpall, Kai Cao

Blood (2022) 140 (Supplement 1): 7649–7650.

https://doi.org/10.1182/blood-2022-166381

Published: 2022

Journal Articles

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Blood (2022) 140 (Supplement 1): 415–416.

https://doi.org/10.1182/blood-2022-156125

Published: 2022

Journal Articles

Impact of Presence and Amount of Clonal Plasma Cells in Autografts Affect Outcomes in High-Risk Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplant

Blood (2022) 140 (Supplement 1): 284–286.

https://doi.org/10.1182/blood-2022-157960

Published: 2022

Journal Articles

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Blood (2019) 134 (Supplement_1): 257.

https://doi.org/10.1182/blood-2019-124921

Published: 2019

Journal Articles

Maintenance with 5-Azacytidine for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

Betul Oran, MDMS, Marcos de Lima, MD, Guillermo Garcia-Manero, MD, Peter F Thall, Ruitao Lin, Amin M. Alousi, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Uday Popat, MD, Sergio Giralt, MD, Sairah Ahmed, MD, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Katy Rezvani, MD PhD, Glenda Woodworth, BSN, OCN, RN, Richard E Champlin, MD

Blood (2018) 132 (Supplement 1): 971.

https://doi.org/10.1182/blood-2018-99-111582

Published: 2018

Journal Articles

Cord Blood Derived Natural Killer Cells Loaded with a Tetravalent Bispecific Antibody Construct (AFM13) As Off-the-Shelf Cell Therapy for CD30+ Malignancies

Blood (2018) 132 (Supplement 1): 341.

https://doi.org/10.1182/blood-2018-99-114954

Published: 2018

Journal Articles

Timed Sequential Busulfan and Post-Transplantation Cyclophosphamide in Matched and Haploidentical Transplantation: Results of a Phase II Study

Blood (2018) 132 (Supplement 1): 3373.

https://doi.org/10.1182/blood-2018-99-113439

Published: 2018

Journal Articles

Post Allogeneic Stem Cell Transplant (SCT) Cyclophosphamide Improves Progression Free Survival (PFS) in Pts with AML/MDS Treated with CTLA-4 or PD-1 Blockade Prior to SCT

Betul Oran, MDMS, Guillermo Garcia-Manero, MD, Rima M. Saliba, PhD, Gheath Alatrash, DO, PhD, Elias J. Jabbour, MD, Uday Popat, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Amin M. Alousi, MD, Marina Y. Konopleva, MD PhD, Courtney D. DiNardo, MDMSc, Katy Rezvani, MD PhD, Mansour Alfayez, MD, Elizabeth J. Shpall, MD, Padmanee Sharma, MD PhD, Richard E Champlin, MD, Hagop M. Kantarjian, MD, Naval G. Daver, MD

Blood (2018) 132 (Supplement 1): 483.

https://doi.org/10.1182/blood-2018-99-115382

Published: 2018

Journal Articles

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Paul Lin, MD PhD, Lauren Westfall Veltri, MD, Katy Rezvani, MD PhD, Betul Oran, MD MS, Sairah Ahmed, MD, Gheath Alatrash, DO, PhD, Rohtesh S. Mehta, MD MPH, MS, Gabriela Rondon, MD, Partow Kebriaei, MD, Uday Popat, MD, Yago Nieto, MD PhD, Chitra Hosing, MD, Roy B Jones, MD PhD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, Elizabeth J. Shpall, MD, Richard E Champlin, MD, David Marin, MD

Blood (2018) 132 (Supplement 1): 4667.

https://doi.org/10.1182/blood-2018-99-112749

Published: 2018

Journal Articles

Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells

Enli Liu, MD, Sonny Ang, PhD, Yijiu Tong, Li Li, MD, Rafet Basar, MD, Lucila Kerbauy, MD, May Daher, Pinaki P Banerjee, PhD, Francesca Lorraine Wei Inng Lim, MD, Indreshpal Kaur, PhD, Richard E Champlin, MD, Elizabeth J. Shpall, MD, Katy Rezvani, MD PhD

Blood (2018) 132 (Supplement 1): 2061.

https://doi.org/10.1182/blood-2018-99-118804

Published: 2018

Journal Articles

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion

Blood (2018) 131 (11): 1248–1257.

https://doi.org/10.1182/blood-2017-07-798751

Published: 2018

Includes: Supplemental data

Journal Articles

Post-Transplant Cyclophosphamide Improves Progression Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients with Prior CTLA-4 or PD-1 Blockade

Betul Oran, MDMS, Guillermo Garcia-Manero, MD, Rima M. Saliba, PhD, Gheath Alatrash, DO, PhD, Elias J. Jabbour, MD, Uday Popat, MD, Farhad Ravandi, MBBS, Amin M. Alousi, Tapan Kadia, MD, Marina Konopleva, MD PhD, Courtney D. DiNardo, MDMSc, Sherry Pierce, BSN, BA, Katy Rezvani, MD PhD, Elizabeth J Shpall, MD, Padmanee Sharma, MD PhD, Richard E. Champlin, MD, Hagop M. Kantarjian, MD, Naval Daver, MD

Blood (2017) 130 (Supplement 1): 3209.

https://doi.org/10.1182/blood.V130.Suppl_1.3209.3209

Published: 2017

Journal Articles

Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival

Blood (2017) 130 (Supplement 1): 3267.

https://doi.org/10.1182/blood.V130.Suppl_1.3267.3267

Published: 2017

Journal Articles

Shortening the Time to Manufacture CAR + T Cells with Sleeping Beauty System Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19 + Tumors

Partow Kebriaei, MD, Helen Huls, Susan Lynn Neel, RN, OCN, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Amy Smith, Elenanor De Groot, Hagop M. Kantarjian, MD, Maro Ohanian, DO, Katy Rezvani, MD PhD, Elizabeth J Shpall, MD, Richard E Champlin, MD, Laurence J N Cooper, MDPhD, Harjeet Singh, MSc, PhD

Blood (2017) 130 (Supplement 1): 2060.

https://doi.org/10.1182/blood.V130.Suppl_1.2060.2060

Published: 2017

Journal Articles

NK Cell Diversity Influences Outcomes after Cord Blood Transplantation

Blood (2017) 130 (Supplement 1): 1979.

https://doi.org/10.1182/blood.V130.Suppl_1.1979.1979

Published: 2017

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia

First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

HLA B-Leader Mismatch Is Associated with Poor Outcomes in NIMA/NIPA Mismatched Haploidentical Sibling Donor HCT

Mother Vs Father Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

A Phase II Clinical Trial of "Off-the-Shelf" NK Cells with Allogeneic Stem Cell Transplantation to Decrease Disease Relapse in Patients with High-Risk Myeloid Malignancies

Son Vs Daughter Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Impact of Presence and Amount of Clonal Plasma Cells in Autografts Affect Outcomes in High-Risk Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplant

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Maintenance with 5-Azacytidine for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

Cord Blood Derived Natural Killer Cells Loaded with a Tetravalent Bispecific Antibody Construct (AFM13) As Off-the-Shelf Cell Therapy for CD30+ Malignancies

Timed Sequential Busulfan and Post-Transplantation Cyclophosphamide in Matched and Haploidentical Transplantation: Results of a Phase II Study

Post Allogeneic Stem Cell Transplant (SCT) Cyclophosphamide Improves Progression Free Survival (PFS) in Pts with AML/MDS Treated with CTLA-4 or PD-1 Blockade Prior to SCT

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion

Post-Transplant Cyclophosphamide Improves Progression Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients with Prior CTLA-4 or PD-1 Blockade

Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival

Shortening the Time to Manufacture CAR + T Cells with Sleeping Beauty System Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19 + Tumors

NK Cell Diversity Influences Outcomes after Cord Blood Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only